Oriza Seed Capital (Oriza Yuandian)

The venture was found in Asia in China. The leading representative office of defined VC is situated in the Suzhou.

The important activity for fund was in 2019. The higher amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The average startup value when the investment from Oriza Seed Capital (Oriza Yuandian) is 500 millions - 1 billion dollars. Opposing the other organizations, this Oriza Seed Capital (Oriza Yuandian) works on 22 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The overall number of key employees were 2.

We can highlight the next thriving fund investment areas, such as Biopharma, Health Care. Among the most popular portfolio startups of the fund, we may highlight Cambricon, CStone Pharmaceuticals, JW Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. The fund has exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Oriza Seed Capital (Oriza Yuandian), startups are often financed by YuanMing Capital, Yonghua Capital, WuXi Healthcare Ventures. The meaningful sponsors for the fund in investment in the same round are YuanMing Capital, Yonghua Capital, TF Capital. In the next rounds fund is usually obtained by YuanMing Capital, SDIC Venture Capital, Yonghua Capital.

Notable deals

Review

• No reviews are submitted yet.